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1 Introduction
Since radioimmunoassays for specific and sensitive
myoglobin measurements are available, they are
increasingly applied in the clinical diagnosis of
hypoxic, traumatic or metabolic lesions in cardiac
and skeletal muscle [1]. Myoglobin assays in
plasma are of special use in the diagnosis and
prognostic assessment of acute myocardial infarc-
tion, crush syndrome and hereditary myopathies,
Duchenne muscular dystrophy for example. Stren-
uous physical exercise and sport activity may in-
crease the serum myoglobin levels [11]. A marked
elevation in plasma myoglobin levels was observed
after tourniquet ischemia [6].
In healthy subjects, myoglobin is present in the
blood at very low levels. Myoglobinemia at ele-
vated levels appears as a result of muscle cell
breakdown or membrane leakage. When myog-
lobin in plasma reaches high concentrations, it is
excreted in the urine in considerable amounts.
Myoglobin is an iron-containing, oxygen-binding,
purple-colored hemoprotein of monomer structure
and a molecular weight of 17.000 daltons (152
amino acids) [7]. Its presence is confined to striated
muscle cells. One mole of myoglobin reversibly
binds one mole of O2. The affinity of myoglobin
to O2 is six to seven times as high as that of
hemoglobin. Thus, myoglobin releases O2 only at
very low oxygen pressures such as occur in muscle
as a consequence of exercise and hypoxia. The
biological function of myoglobin is oxygen storage
within the muscle cells and its release to the en-
ergy-providing mitochondria on demand [2].
Skeletal and cardiac muscle of long-term diving
animals, whales and seals for example, are very
rich in myoglobin; the oxygen storage property of
myoglobin enables them spending longer periods
of time underwater. The human fetus is living and
growing under low oxygen pressure, and it is not
seldom exposed to life-threatening periods of hy-
poxia and asphyxia, suggesting that myoglobin
may be of relevance to the fetus at risk.
In the pertinent literature there were currently no
established levels for amniotic fluid myoglobin in
late pregnancy, nor any indications as to their
clinical significance. Therefore, the major objec-
tives of the present pilot study were the following:
to investigate whether and to what extent myog-
lobin was detectable in human amniotic fluid an-
tepartum and intrapartum, and whether elevated
amniotic fluid myoglobin levels were concomitant
with certain pathological conditions such as fetal
distress provoked by intrauterine hypoxia or in-
trapartal muscle injury on vaginal delivery.
2 Materials and methods
195 amniotic fluid samples from the third trimester
were assayed for their content of myoglobin. 151
of them were obtained by transcervical amniocen-
tesis intrapartum. The rest of 44 samples was taken
by ultrasound-guided amniocentesis antepartum.
The antenatal withdrawals of amniotic fluid were
generally made within one week prior to delivery.
They were chiefly performed to assess fetal lung
maturity by means of phospholipid analyses in the
liquor.
In order to separate cells, detritus and vernix from
amniotic fluid, the samples were centrifuged at
1100 g for 10 minutes. Until processing they were
stored in polypropylene tubes at — 20 °C.
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Myoglobin was determined by radioimmunoassay
with reagents supplied by Commissariat a Fenergie
atomique, Gif-sur-Yvette, France, and by Sorin
Biomedica, Saluggia, Italy. 125I-labeled human
myoglobin was used as the tracer, and highly pur-
ified human myoglobin was applied for the stand-
ards. The myoglobin antiserum from rabbit had
full reactivity with human myoglobin and no
cross-reactivities with related compounds of hu-
man origin, especially with hemoglobin. Even in-
tense hemolytic admixture with the amniotic fluid
did not interfere with the assay. The separation of
the bound and the free fraction was accomplished
with an immuno-precipitating agent containing a
second antibody raised in the donkey and directed
towards the rabbit antiserum, and polyethylene
glycol solution. The RIA-sensitivity was 3 ng
myoglobin per ml (B0—2sB0). At concentrations
of 15 ng myoglobin per ml, the intra-assay and
inter-assay coefficients of variation were 5.1 and
6.5 per cent respectively.
The sample volume per RIA tube was 0.1 ml. The
myoglobin assays were, performed in triplicate for
the standard solutions and in duplicate for the
amniotic fluid samples.
3 Results
Depending on the myoglobin levels measured, dif-
ferent amniotic fluid groups could be formed: (A)
amniotic fluids containing no myoglobin or traces
of it (< 3 ng/ml), (B) amniotic fluid samples with
moderately elevated myoglobin levels (3 — 10 ng/
ml) and (C) amniotic fluids with high myoglobin
levels (> 10 ng/ml).
The above-defined groups were brought in relation
to findings of perinatal fetal monitoring, course
and mode of delivery and neonatal outcome.
3.1 Myoglobin in amniotic fluid intrapartum
As can be seen from tables I and II, almost two
thirds of the amniotic fluid samples taken intra-
partum (n = 98, 64.9% of 151) had myoglobin
levels above 3 ng/ml (range 3.7-184 ng/ml). The
individual values are represented in figure 1. The
rest of 53 samples contained no myoglobin or
traces of it which lay below the lower limit of
detection of the radioimmunoassay used in this
study.
Table I. Intrapartum myoglobin levels in amniotic fluid and selected clinical parameters
Mb < 3 ng/ml
(Group A)
Mb 3-10 ng/ml
(Group B)
Mb > 10 ng/ml
(Group C)
Amniotic fluid samples assayed
Full-term infants1
Premature infants
Birthweight (means and s. d.)
all infants examined
Placental weight (means and s. d.)
all cases examined
Small-for-date neonates2
mean weight
Large-for-date neonates3
mean weight
Delivery by cesarean section
n = 53
98.1% (= 52/53)
1.9% (= 1/53)
(wk. 36)
3530 (529) g
633 (121) g
3.8% (= 2/53)
2650g
20.8% (= 11/53)
4270g
5.7% (= 3/53)
n = 54
87.0% (= 47/54)
13.0% (= 7/54)
(wks. 34-36)
3420 (511) g
666 (160) g
7.4% (= 4/54)
2606g
20.4% (= 11/54)
3988g
13.0% (= 7/54)
n = 44
86.4% (= 38/44)
13.6% (= 6/44)
(wks. 31-36)
3260 (697) g
593 (141) g
9.1% (= 4/44)
2053 g
9.1% (= 4/44)
4096g
18.2% (= 8/44)
1
 Full-term infants: delivery at 37 to 42 weeks of gestation
2
 Small-for-date infants: infants with a birthweight below the 10th percentile for gestational age according to NICKL
[10]
3
 Large-for-date infants: infants with a birthweight above the 90th percentile for gestational age according to NICKL
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Table Π. Intrapartum myoglobin levels in amniotic fluid related to findings of fetal and neonatal monitoring
Amniotic fluid samples assayed
Pathological CTG1 antepartum
Pathological CTG intrapartum
Meconium-stained amniotic fluid
Metabolic acidosis2 in the neonate
immediately after delivery
Neonatal depression3
immediately postpartum
Neonatal depression
5 min postpartum
Mb < 3 ng/ml
(Group A)
n = 53
0% (= 0/26)
5.1% (= 2/39)
22.6% (= 11/53)
7.5% (= 4/53)
3.8% (= 2/53)
0% (= 0/53)
Mb 3 -10 ng/ml
(Group B)
n = 54
0% (= 0/7)
15.0% (= 3/20)
27.8% (= 15/54)
11.3% (= 6/53)
0% (= 0/54)
0% (= 0/54)
Mb > 10 ng/ml
(Group C)
n = 44
8.0% (= 2/25)
24.1% (= 7/29)
38.6% (= 17/44)
23.3% (= 10/43)
11.4% (= 4/44)
2.3% (1/44)
1
 CTG evaluation according to FIGO Guidelines 1987 [3].
The number of the amniotic fluid samples assayed is not necessarily in accordance to that of monitoring data, since
the specified examinations were not performed in each of the examined pregnancies.
2
 pHqu40 < 7.25 in umbilical artery blood; pHqu40 = pH after equilibration with pCO2 40 mm Hg3
 Neonatal depression: < 7 points of modified APGAR score [12].
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Figure 1. Distribution of the individual myoglobin levels
in amniotic fluid above 3 ng/ml. Black dots = myo-
globin in amniotic fluid taken intrapartum; open trian-
gles = myoglobin in amniotic fluid drawn antepartum
Table I shows that in Group C (high myoglobin
levels) the prevalence of premature and small-for-
date infants was larger than in Group A and B.
In Group C there were 18.2% of cesarean deliv-
eries due to protracted labor and/or fetal distress,
compared to only 5.7% in Group A (p < 0.05,
χ2 = 5.10, 1 degree of freedom). The 13% of ce-
sareans in Group B were between the values of
Group A and C.
The relative frequency of meconium-stained am-
niotic fluid samples was significantly higher in
Group C than in Group A (p < 0.05, χ2 = 4.04);
table II. The prevalence of metabolic acidosis
(pHqu40 < 7,25) in the neonate immediately after
delivery was three times as high in Group C as in
Group A (p < 0.025, χ2 = 6.05). Among the car-
diotocograms recorded intrapartum there were
considerably more pathological findings in Group
C (24.1%) than in Group A (5.1%); p < 0.01,
χ2 = 7.02.
Neonatal depression immediately postpartum
(Apgar < 7 points) amounted to 11.4% in Group
C compared to 3.8% in Group A, a remarkable
difference which, however, did not reach the limit
of statistical significance of p < 0.05. Large-for-
date neonates were under-represented in Group C
compared with their occurrence in the two other
groups.
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3.2 Myoglobin in amniotic fluid antepartum
Out of the 44 amniotic fluid samples drawn an-
tepartum, only 10 (= 22.7%) had myoglobin con-
centrations exceeding 3 ng/ml (range 3.1—39 ng/
ml). The individual levels are shown in figure 1
(open triangles).
25 of the antepartal amniotic fluid samples came
from pregnancies resulting in preterm delivery, the
rest from pregnancies with full-term babies. In
Group C the proportion of pregnancies leading to
preterm birth was very high (table III).
More than half of the neonates in Group B and
C was delivered by cesarean section because of
imminent or incipient intrapartum fetal distress.
In the pregnancies with myoglobin-positive am-
niotic fluid samples antepartum, the relative fre-
quency of cesarean deliveries was significantly
higher than that in pregnancies with no myoglobin
in the liquor amnii antepartum (B + C vs. A,
p < 0.025, χ2 = 6.57). In Group C more mecon-
ium-stained amniotic fluid samples were to be
found than in Group A (p < 0.05, χ2 = 4.98). Sim-
ilarly, more pathological findings were noticed in
Table ΙΠ. Antepartum myoglobin levels in amniotic fluid and selected clinical parameters
Amniotic fluid samples assayed
Full-term infants
Premature infants
Birthweight (means and s. d.)
all infants examined
Placental weight (means and s. d.)
all cases examined
Delivery by cesarean section
Mb < 3 ng/ml
(Group A)
η = 34
50.0% (= 17/34)
50.0% (= 17/34)
wks. 31-36
2942 (638) g
587 (117) g
23.5% (= 8/34)
Mb 3 -10 ng/ml
(Group B)
n = 3
33.3% (= 1/3)
66.6% (= 2/3)
wks. 31-36
2020 (698) g
373 (119) g
66.6% (= 2/3)
Mb > 10 ng/ml
(Group C)
n = 7
14.3% (= 1/7)
85.7% (= 6/7)
wks. 30-36
2047 (800) g
431 (198) g
57.1% (= 4/7)
Table IV. Antepartum myoglobin levels in amniotic fluid related to findings of fetal and neonatal monitoring
Amniotic fluid samples assayed
Pathological CTG antepartum
Meconium-stained amniotic fluid
antepartum
Meconium-stained amniotic fluid
intrapartum
Pathological CTG intrapartum
Metabolic acidosis in the neonate
immediately after delivery
Neonatal depression
immediately postpartum
Neonatal depression
5 min postpartum
Mb < 3 ng/ml
(Group A)
n = 34
6.7% (= 2/30)
2.9% (= 1/34)
11.8% (= 4/34)
17.2% (= 5/29)
11.8% (= 4/34)
11.8% (= 4/34)
2.9% (= 1/34)
Mb 3 -10 ng/ml
(Group B)
n = 3
0% (= 0/2)
0% (= 0/3)
0% (= 0/3)
-
0% (= 0/3)
33.3% (= 1/3)
0% (= 0/3)
Mb > 10 ng/ml
(Group C)
n = 7
25.0% (= 2/8)
14.3% (= 1/7)
14.3% ( = 1/7)
33.3% (= 2/6)
14.3% (= 1/7)
57.1% (= 4/7)
28.6% (= 2/7)
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the antepartally recorded cardiotocograms of
Group C in comparison with those of Group A
(p < 0.05, χ2 = 4.62); table IV.
The occurrence of neonatal depression immedi-
ately postpartum was greatly elevated in Group Β
(33%) and in Group C (57%), related to the
approximate 12% in Group A (A vs. C, ρ < 0.01,
χ2 = 10.77). 5 minutes later, the depression rate in
Group C was still close to 29%, whereas in Groups
A and Β it had meanwhile been minimized.
The rate of metabolic acidosis in the neonates
immediately postpartum did not differ remarkably
in the myoglobin-positive groups from that in the
myoglobin-negative one.
4 Discussion
As it is shown by the foregoing results, elevated
myoglobin levels in third trimester amniotic fluid
are particularly often connected with clinically
manifest disorders of pregnancy in the antepartum
period or during labor.
In the myoglobin-positive intrapartum cases, the
statistical prevalence of pathological cardiotoco-
grams during labor, of meconium-stained amniotic
fluids, of metabolic acidoses in umbilical artery
blood immediately after delivery and — not at
least — of an increased rate of emergency cesarean
sections give us reason for assuming that episodes
of fetal hypoxemia may play a major part in the
appearance of myoglobin in amniotic fluid. In our
random sample, macrosomia is not associated
with raised myoglobin levels in amniotic fluid.
In the pregnancies with positive amniotic fluid
myoglobin Undings antepartum, there is also a
statistical prevalence in clinical signs pointing to
fetal hypoxic distress such as pathological cardi-
otocograms antepartum and increased antepartal
appearance of meconium in amniotic fluid. The
rate of cesarean births for fetal distress is signifi-
cantly increased in the groups showing elevated
amniotic fluid myoglobin levels antepartum com-
pared with the myoglobin-negative group. Neo-
natal depression immediately postpartum was very
frequent among the infants of Group B and C,
who were to a larger proportion premature and
delivered by cesarean section under general anes-
thesia.
Recently JENSEN et al [5] investigated the effect of
acute asphyxia (4 min arrest of uterine blood flow
in the mother animal) on blood flow distribution
in central and peripheral organs — including skel-
etal muscle - of unanesthetized fetal sheep near
term. As soon as one minute after onset of as-
phyxia, they found an extreme drop in muscle
perfusion to 2 — 3% of that in the unasphyxiated
control animals. Simultaneously the blood flow to
vital organs such as heart, brain stem and adrenals
remained nearly unchanged and even increased
slowly later on.
The relevant observations strengthened our pre-
vious working hypothesis as to the probable origin
of myoglobin in amniotic fluid: periods of serious
intrauterine hypoxia provoke a hemicirculatory
centralization and a profound reduction in blood
and oxygen supply to skeletal muscle non-vital to
the fetus [13]. This may lead to a membrane leak-
age in skeletal muscle resulting in myoglobin loss
from the myocytes, transitory hypermyoglobine-
mia and consecutive myoglobin excretion to am-
niotic fluid.
Since some degree of hypoxemia is almost inevi-
table in most fetuses during (complicated) vaginal
delivery, this may explain the increased rate of
elevated myoglobin in amniotic fluid intrapartum
(64.9%) in contrast to amniotic fluid antepartum
(22.7%).
Serum myoglobin levels were found to be signifi-
cantly elevated in asphyxiated neonates immedi-
ately after delivery compared with newborn con-
trol infants [8]. In this context a paper of HAFTEL
et al [4] should be mentioned reporting a case of
myoglobinuric renal failure in a newborn infant
who was severely depressed and had persistent
hypoxia and acidosis for several hours after par-
turition.
Serum myoglobin levels in neonates immediately
postpartum do not correlate significantly with
those in their mothers and are higher than the
maternal ones, suggesting that myoglobin transfer
across the placental barrier, which could influence
the myoglobin concentrations in amniotic fluid, is
extremely low and negligible [15].
In two cases, elevated myoglobin levels in second
trimester amniotic fluid from fetuses with Duch-
enne muscular dystrophy were described [14, 9].
So far, there were no studies in the literature
dealing with causal connections between amniotic
fluid myoglobin in the perinatal period and hy-
poxia in the fetus. The present study demonstrates
that detection of high myoglobin levels in amniotic
fluid during late pregnancy or labor may prove to
be an additional new sign of fetal distress.
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Summary
195 amniotic fluid samples from the third trimester were
examined for their content of myoglobin by means of
radio-immunoassay. 151 of the samples were obtained
intrapartum, the rest (44) was taken antepartum by
transabdominal amniocentesis within one week prior to
delivery. Depending on the myoglobin levels measured,
different amniotic fluid groups were defined: (A) am-
niotic fluids containing no myoglobin or traces of it
(<3ng/ml), (B) amniotic fluids with moderately ele-
vated myoglobin levels (3 — 10 ng/ml), (C) amniotic
fluids with high myoglobin levels (> 10 ng/ml). Myo-
globin levels above 3 ng/ml could be measured in 98 of
the 151 samples taken intrapartum. In the amniotic
fluids drawn antepartum the proportion of "myoglobin-
positive" samples (> 3 ng/ml) amounted to only 22.7%
(10 out of 44 samples).
In pregnancies with amniotic fluids showing high myog-
lobin levels intrapartum, the prevalance of meconium
staining of the samples, pathological cardiotocograms
intrapartum and metabolic acidoses in umbilical artery
blood samples was significantly higher than in pregnan-
cies with myoglobin-negative amniotic fluids. The fre-
quency of cesarean sections for fetal distress rose with
increasing myoglobin levels in amniotic fluid, being 5.7,
13, and 18.2% in Group A, B and C respectively.
In the pregnancies in which the amniotic fluid samples
were taken antepartum, the prevalence of meconium-
stained amniotic fluid increased with elevating amniotic
fluid myoglobin (p < 0.05, Group A vs. Group C). The
frequency of cesarean sections for fetal distress and of
neonatal depression immediately after delivery was con-
siderably heightened in the cases with myoglobin-posi-
tive amniotic fluids antepartum compared to those with
myoglobin-negative liquor. The antepartum withdrawals
of amniotic fluid were performed predominantly in preg-
nancies at risk that resulted in preterm delivery. Elevated
myoglobin levels in amniotic fluid were mainly associ-
ated with an increased prevalence of fetal distress, com-
plicated delivery, and prematurity.
On the assumption that transient seepage of fetal muscle
myoglobin into amniotic fluid occurs after periods of
fetal hypoxia, the evidence of elevated myoglobin levels
in antepartum amniotic fluid appears to be an additional
new indicator of hypoxic impairment in the fetus.
Keywords: Amniotic fluid, complicated delivery, fetal distress, hypoxia, myoglobin, neonatal outcome, prematurity.
Zusammenfassung
Myoglobin im Fruchtwasser aus dem dritten Trimenon der
menschlichen Schwangerschaft — ein potentielles Hin-
weiszeichen auf fetale Hypoxie
195 Fruchtwasserproben aus dem dritten Trimenon wur-
den mittels Radioimmunoassay auf ihren Myoglobin-
gehalt untersucht. 151 Proben wurden intra partum ent-
nommen, die übrigen 44 ante partum in der Woche vor
der Entbindung. Abhängig von den gemessenen Myo-
globinkonzentrationen, wurden verschiedene Frucht-
wassergruppen definiert: (A) Fruchtwässer mit Myoglo-
binspuren oder ohne Myoglobin (< 3 ng/ml), (B)
Fruchtwässer mit mäßig erhöhten Myoglobinkonzentra-
tionen (3 — 10 ng/ml), (C) Fruchtwässer mit hohen Myo-
globinkonzentrationen (> 10 ng/ml). Myoglobinkon-
zentrationen über 3 ng/ml wurden bei 98 der intra par-
tum entnommenen Proben gemessen, d. s. 64.9%. In der
ante partum gewonnenen Fruchtwässern betrug der An-
teil der „myoglobin-positiven" Proben nur 22.7% (10
aus 44 Proben).
Bei Schwangerschaften mit Fruchtwassern, die intra par-
tum hohe Myoglobinkonzentrationen aufwiesen, war die
Prävalenz von Mekonium im Fruchtwasser, pathologi-
schen Kardiotokogrammen intra partum und metaboli-
schen Azidosen im Nabelarterienblut der soeben Neu-
geborenen signifikant höher als bei Schwangerschaften
mit „myoglobin-negativem" Fruchtwasser. Die Sektio-
frequenz wegen fetaler Notsituation stieg mit höheren
Myoglobinkonzentrationen im Fruchtwasser an, und
zwar von 5.7% über 13% auf 18.2% in den Gruppen
A, B bzw. C.
Bei den Schwangerschaften mit Entnahme von Frucht-
wasserproben ante partum gab es eine steigende Präva-
lenz von Mekonium im Fruchtwasser und pathologi-
schen Kardiotokogrammen ante partum, je höher die
Myoglobinkonzentrationen in den Fruchtwasserproben
waren. Die Häufigkeit von Kaiserschnitten wegen fetaler
Notsituation sowie von neonatalen Depressionen sofort
post partum war in den Fällen mit myoglobin-positiven
Fruchtwässern deutlich erhöht im Vergleich zu den myo-
globin-negativen Fällen.
Die antepartualen Fruchtwasserentnahmen wurden vor-
wiegend bei Risikoschwangerschaften durchgeführt, die
mit Frühgeburten endeten.
Erhöhte Myoglobinkonzentrationen im Fruchtwasser
gingen hauptsächlich mit einer vermehrten Prävalenz
von Symptomen der Fetalgefahrdung, komplizierten
Entbindung und Frühgeburten einher.
Unter der Annahme, daß vorübergehender Myoglobin-
austritt vom fetalen Muskel ins Fruchtwasser vor allem
nach Hypoxieperioden auftritt, scheint der Nachweis
von erhöhten Myoglobinkonzentrationen im Frucht-
wasser ante partum ein zusätzliches, neues Hinweiszei-
chen auf hypoxische Beeinträchtigung des Feten darzu-
stellen.
Schlüsselwörter: Entbindungskomplikationen, fetale Notsituation, Frühgeburtlichkeit, Hypoxie, Myoglobin im
Fruchtwasser, Neugeborenenzustand.
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Resume
Un indicateur potentiel d'hypoxie fcetale: la myoglobine
dans le liquide amniotique au cours du troisieme trimestre
de la grossesse humaine
On a etudie au moyen de dosage radio-immunologique
la teneur en myoglobine de 195 echantillons de liquide
amniotique au cours du troisieme trimestre: 151 echan-
tillons ont etc obtenus pendant le travail, le reste (44) a
ete preleve par amniocentese transabdominale au cours
de la semaine precedant Faccouchement. On a defini
differents groupes de liquides amniotiques en fonction
des taux de myoglobine:
a/ — Les liquides n'en contenant pas ou des traces
(inferieur ä 3 ng/ml)
b/ — Les liquides en contenant des taux moyennement
eleves (3-10 ng/ml)
c/ — Les liquides avec taux eleves (superieur a 10 ng/ml).
On a mesure des taux de myoglobine superieurs a 3 ng/
ml dans 98 des 151 echantillons preleves en par partum.
Parmi les liquides amniotiques preleves en pre partum
la proportion de liquides «myoglobine positifs» n'est
que de 22,7% (10 des 44).
La prevalence de liquide teintes, de cardiotocogrammes
pathologiques pendant le travail et d'acidose metabo-
lique au sang arteriel ombilical est significativement plus
elevee pour les grossesses dont les liquides amniotiques
montraient des taux eleves de myoglobine en par partum
que pour les grossesses avec des liquides sans myoglo-
bine.
La frequence des cesariennes pour souffrance foetale
s'eleve avec l'augmentation du taux de myoglobine du
liquide amiotique, eile est respectivement de 5,7, 13,
18,2% dans les groupes a, b et c.
Pour les grossesses dont le liquide amniotique a ete
preleve en pre partum, la prevalence des liquides teintes
et de cardiotocogrammes pre partum pathologiques
s'eleve avec l'augmentation de la myoglobine (p inferieur
ä 0,05, groupe a VS groupe c). La frequence des cesa-
riennes pour souffrance foetale et des depressions neo-
natales immediatement apres la naissance est conside-
rablement plus grande dans les cas ou les liquides am-
niotiques pre partum sont «myoglobine positifs» en
comparaison des liquides «myoglobine negatifs». Les
prelevements pre partum des liquides amniotiques ont
ete realises avant tout lors de grossesse ä risque entrai-
nant des accouchements prematures. Des taux eleves de
myoglobine s'accompagnant principalement d'une ele-
vation de la prevalence des souffrances foetales, d'accou-
chements prematures et de prematurite.
Dans l'hypoxie ou survient un passage transitoire de la
myoglobine musculaire foetale dans le liquide amniotique
apres des periodes d'anoxie foetale, l'apparition de taux
eleves de myoglobine dans le liquide amniotique en pre
partum semble etre un nouvel indicateur supplementaire
d'hypoxie foetale.
Mots-cles: Accouchement complique, devenier neonatal, hypoxie, liquide amniotique, myoglobine, prematurite,
souffrance foetale.
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